Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups

B. Ledergerber; A. Mocroft; P. Reiss; H. Furrer; O. Kirk; M. Bickel; C. Uberti-Foppa; C. Pradier; D' Arminio Monforte; M.M.E. Schneider; J.D. Lundgren; [No Value] Eight European Study Groups

Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups

Translated title of the contribution: Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups

B. Ledergerber, A. Mocroft, P. Reiss, H. Furrer, O. Kirk, M. Bickel, C. Uberti-Foppa, C. Pradier, D' Arminio Monforte, M.M.E. Schneider, J.D. Lundgren, [No Value] Eight European Study Groups

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups
Original language	Undefined/Unknown
Pages (from-to)	168-174
Number of pages	7
Journal	New England Journal of Medicine
Volume	344
Issue number	3
Publication status	Published - 2001

Cite this

Ledergerber, B., Mocroft, A., Reiss, P., Furrer, H., Kirk, O., Bickel, M., Uberti-Foppa, C., Pradier, C., Arminio Monforte, D., Schneider, M. M. E., Lundgren, J. D., & Eight European Study Groups, N. V. (2001). Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups. New England Journal of Medicine, 344(3), 168-174.

@article{4b202b73f4a748f38fd506bde5ccdeb3,

title = "Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups",

author = "B. Ledergerber and A. Mocroft and P. Reiss and H. Furrer and O. Kirk and M. Bickel and C. Uberti-Foppa and C. Pradier and {Arminio Monforte}, D' and M.M.E. Schneider and J.D. Lundgren and {Eight European Study Groups}, {[No Value]}",

year = "2001",

language = "Undefined/Unknown",

volume = "344",

pages = "168--174",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "3",

}

Ledergerber, B, Mocroft, A, Reiss, P, Furrer, H, Kirk, O, Bickel, M, Uberti-Foppa, C, Pradier, C, Arminio Monforte, D, Schneider, MME, Lundgren, JD & Eight European Study Groups, NV 2001, 'Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups', New England Journal of Medicine, vol. 344, no. 3, pp. 168-174.

Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups. / Ledergerber, B.; Mocroft, A.; Reiss, P. et al.
In: New England Journal of Medicine, Vol. 344, No. 3, 2001, p. 168-174.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups

AU - Ledergerber, B.

AU - Mocroft, A.

AU - Reiss, P.

AU - Furrer, H.

AU - Kirk, O.

AU - Bickel, M.

AU - Uberti-Foppa, C.

AU - Pradier, C.

AU - Arminio Monforte, D'

AU - Schneider, M.M.E.

AU - Lundgren, J.D.

AU - Eight European Study Groups, [No Value]

PY - 2001

Y1 - 2001

M3 - Article

SN - 0028-4793

VL - 344

SP - 168

EP - 174

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 3

ER -